Compare BXSL & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BXSL | SHC |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.6B |
| IPO Year | 2018 | 2020 |
| Metric | BXSL | SHC |
|---|---|---|
| Price | $23.44 | $15.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $27.18 | $20.33 |
| AVG Volume (30 Days) | 1.5M | ★ 2.3M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 12.87% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | ★ 0.11 | 0.09 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | N/A | $7.51 |
| Revenue Next Year | N/A | $6.00 |
| P/E Ratio | $216.45 | ★ $178.22 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $22.47 | $10.94 |
| 52 Week High | $32.81 | $19.85 |
| Indicator | BXSL | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.33 | 45.64 |
| Support Level | $23.27 | $15.00 |
| Resistance Level | $24.99 | $16.47 |
| Average True Range (ATR) | 0.42 | 0.52 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 31.83 | 34.64 |
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.